RET-IN-8

For research use only. We do not sell to patients.

RET-IN-8

CAS No. : 2642164-75-6

Biological Activity:RET-IN-8 is a rearranged during transfection (RET) kinase inhibitor extracted from patent WO2021093720A1 compound I-1. RET-IN-8 can be used for the research of cancer.

Research Area:Cancer

Targets:RET

Related Small Molecules:RET-IN-18;Zeteletinib;RET-IN-5;GSK3179106;Pyrazoloadenine;trans-Pralsetinib;PF 477736;BT-13;AD80;JNJ-38158471;Amuvatinib hydrochloride;RET-IN-11;TRK II-IN-1;RET-IN-10;RET-IN-17;RET-IN-7;RET-IN-13;TG101209;WHI-P180;TAS05567;RET-IN-14;FLT3/ITD-IN-4;Pz-1

Trending products:Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Fluorescent Dye  |  PROTAC  |  Isotope-Labeled Compounds  |  Oligonucleotides

About Us:

  • MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use;
  • Structurally and synthetically diverse biologically active compounds;
  •  roduct quality is the key to our success and we take pride in offering only the highest-grade products.;
  • We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.;
  • Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.;
  • Structurally and synthetically diverse biologically active compounds;

  • Customized order volume ranging from milligrams to kilograms scale;
  • We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.

50K Diversity Library
Top Publications Citing Use of MCE Products
Recombinant Proteins
magnetic-beads